Lung Diseases: all 3,319 studies

Page 9 of 34. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.

• Comparison of Efficacy of Indacaterol Versus Placebo Over 12 WeeksCompletedNCT01068600Phase 3Results posted
• Simvastatin Therapy for Moderate and Severe COPDTerminatedNCT01061671Phase 3Results posted
• Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01054885Phase 3Results posted
• Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01054170Phase 2Results posted
• A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01053988Phase 3Results posted
• Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and PlaceboCompletedNCT01049360Phase 2Results posted
• Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®CompletedNCT01048333Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01047553Phase 3Results posted
• Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)CompletedNCT01045161Phase 3Results posted
• Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)CompletedNCT01044459Phase 3Results posted
• Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry IICompletedNCT01040793Phase 3Results posted
• A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01040728Phase 3Results posted
• Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01040689Phase 3Results posted
• Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01040403Phase 2Results posted
• Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry ICompletedNCT01040130Phase 3Results posted
• Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExampleCompletedNCT01036763Results posted
• A Study To Examine The Safety, Pharmacokinetics And Pharmacodynamics Of PF-03635659 In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01033487Phase 2Results posted
• Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/FormoterolCompletedNCT01023516Phase 2Results posted
• Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01019694Phase 3Results posted
• A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01017952Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01009463Phase 3Results posted
• Reducing Dynamic Hyperinflation Through Breathing RetrainingCompletedNCT01009099Phase 2/3Results posted
• A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus PlaceboCompletedNCT01005901Phase 3Results posted
• Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01001494Phase 3Results posted
• Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory CapacityCompletedNCT00999908Phase 3Results posted
• The Effects of Broccoli Sprout Extract on Obstructive Lung DiseaseCompletedNCT00994604Not applicableResults posted
• Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00984659Phase 4Results posted
• Inhaled Corticosteroid Withdrawal in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00975195Phase 4Results posted
• Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00974220Not applicableResults posted
• Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)CompletedNCT00970268Phase 3Results posted
• Fetal Tracheal Balloon Study in Diaphragmatic HerniaTerminatedNCT00966823Phase 2Results posted
• Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00958919Not applicableResults posted
• Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature NewbornsCompletedNCT00955487Phase 2Results posted
• GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary DiseaseCompletedNCT00950807Phase 2Results posted
• A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With TiotropiumCompletedNCT00949975Phase 2Results posted
• The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00939211Phase 2Results posted
• Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung DiseaseCompletedNCT00934362Phase 2Results posted
• Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00932646Phase 3Results posted
• Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00931385Phase 3Results posted
• Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00929734Phase 2Results posted
• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00929110Phase 3Results posted
• Actuation Indicator Trial in Patients With COPDCompletedNCT00928746Phase 3Results posted
• To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00917150Phase 2Results posted
• Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00914810Phase 3Results posted
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00909779Phase 3Results posted
• A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00900731Phase 3Results posted
• Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)CompletedNCT00891462Phase 3Results posted
• Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)CompletedNCT00883129Phase 2Results posted
• Implemental Flutter Mucus Clearance Devices on Geriatric Lung FunctionCompletedNCT00881335Not applicableResults posted
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00877383Phase 3Results posted
• Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00876694Phase 3Results posted
• Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With EmphysemaTerminatedNCT00874497Phase 2Results posted
• The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00870896Early Phase 1Results posted
• Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00868231Phase 2Results posted
• Does Pulmonary Rehabilitation Improve Balance in People With Respiratory Disease?CompletedNCT00864084Phase 1Results posted
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00862641Phase 4Results posted
• A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00857766Phase 4Results posted
• A Study to Investigate the Bronchodilatory Effect of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00856193Phase 2Results posted
• BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPDCompletedNCT00846768Phase 2Results posted
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00846586Phase 3Results posted
• Hyperpolarized Noble Gas MR Imaging for Pulmonary DisordersTerminatedNCT00846573Not applicableResults posted
• Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRICompletedNCT00846287Not applicableResults posted
• Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedNCT00841971Phase 4Results posted
• Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00821093Phase 3Results posted
• ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPDCompletedNCT00801684Phase 2Results posted
• Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease IICompletedNCT00796653Phase 3Results posted
• Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00794157Phase 3Results posted
• Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease ICompletedNCT00793624Phase 3Results posted
• Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00792805Phase 3Results posted
• Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator MonotherapyCompletedNCT00791518Results posted
• A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00784550Phase 4Results posted
• 12 / 48 wk Pivotal PFT vs PBO in COPD IICompletedNCT00782509Phase 3Results posted
• 12 / 48 Week Pivotal PFT vs PBO in COPD ICompletedNCT00782210Phase 3Results posted
• 14729-D9831C00002- 1 Month Biopsy StudyCompletedNCT00766415Phase 2Results posted
• A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00758706Phase 2Results posted
• Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00758459Phase 2Results posted
• Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPDCompletedNCT00749411Phase 2Results posted
• Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")TerminatedNCT00747461Phase 4Results posted
• Reproducibility of 6 Minute Walk Tests for Oxygen DesaturationCompletedNCT00740220Results posted
• A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00739648Phase 2Results posted
• Comparison of Repetitive Magnetic Stimulation and Exercise on Quadriceps Function in COPDCompletedNCT00737698Not applicableResults posted
• A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysCompletedNCT00732472Phase 2Results posted
• A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00731822Phase 2Results posted
• Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00720499Phase 2Results posted
• Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. AeruginosaCompletedNCT00712166Phase 3Results posted
• Comparison of Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00706914Phase 2Results posted
• Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionCompletedNCT00705133Phase 2Results posted
• PleuraSeal Post Market Study (Europe)CompletedNCT00704171Phase 4Results posted
• A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00703391Phase 2Results posted
• Observational Non-Interventional Study With Spiriva Respimat in COPD PatientsCompletedNCT00699699Results posted
• SUN11031 in Cachexia Associated With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00698828Phase 2Results posted
• Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)CompletedNCT00696020Phase 2Results posted
• Long-term Oxygen Treatment TrialCompletedNCT00692198Phase 3Results posted
• Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00680056Phase 4Results posted
• Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00677690Phase 3Results posted
• The Natural History of Small Airways Physiology in Diseased and Healthy StatesCompletedNCT00677560Results posted
• Dose-Ranging Study Of GSK233705B In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00676052Phase 2Results posted
• An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.CompletedNCT00674817Phase 2Results posted
• Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00669617Phase 3Results posted
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary DiseaseTerminatedNCT00642616Phase 3Results posted

← Lung Diseases overview